Main > A1. CORP. INDEX. In-Iz > Isis Pharmaceuticals/P
This data is not available for free
Isis Pharmaceuticals/P's subsections
1998. 12.18.1998. (Gilead Sciences)
2000. 01.24.2000. (Crohn s Disease)
2000. 10.02.2000. (Parent of)
2001. 08.27.2001. (Oncology)
2001. 09.24.2001. (AIDS/Ophthalmo)
2001. 09.24.2001. (Oncology)
2001. 09.24.2001. (Supplier)
2002. 06.24.2002. (Oncology)
2002. 10.07.2002. (Oncology)
2002. 10.14.2002. (Contact)
2002. 10.14.2002. (Funct. Genomics)
2002. 10.14.2002. (Parent of)
2002. 10.14.2002. (Target Validn.)
2003. 04.07.2003. (Oncology)
2003. 04.28.2003. (Oncology)
2003. 07.28.2003. (Executive)
2005. 02.14.2005. (Onco>Sarissa)
2005. 05.30.2005. (Pfizer Deal)
2007. 11.27.2007. (Fibrotic Diseas)
2008. 04.08.2008. (Cardio.>BMS)
2009. 04.29.2009. (Alnylam)
2012. 03.07.2012. Onco.>HCC &
2012. 08.30.2012. Single-"Stranded"
2012. 10.18.2012. CV.>HoFH
2013. 04.08.2013. Neuro.>HD Roche
2013. 06.06. AstraZeneca
2013. 07.30. FAP>ISIS-TTR Rx>GSK
2013. 08.05. Rheuma.>RA
2013. 08.31. CV.>Triglycerides
2014. 01.13. Alnylam
2014. 02.21. Children>SMA
2014. 05.14. Diab.>ISIS-GCGR Rx
2014. 06.10. AstraZeneca
2014. 06.17. Biogen Idec
2014. 11.13. AstraZeneca
2014. 12.07. VTE>ISIS-FXI Rx
2015. 06.05. Bayer
Patents
Web-Site
Z - OK
Isis Pharmaceuticals/P's products
This section has no products